About Us

Search Results


PMID 18834967
Gene Name CHD7
Condition Idiopathic hypogonadotropic hypogonadism, Kallmann syndrome
Association The findings indicate that both normosmic IHH and KS are mild allelic variants of CHARGE syndrome and are caused by CHD7 mutations.
Population size 281
Population details 281 (101 IHH/KS patients, 180 controls)
Sex Male
Infertility type Male infertility
Other associated phenotypes Idiopathic hypogonadotropic hypogonadism, Kallmann syndrome


Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome

Kim HG, Kurth I, Lan F, Meliciani I, Wenzel W, Eom SH, Kang GB, Rosenberger G, Tekin M, Ozata M, Bick DP, Sherins RJ, Walker SL, Shi Y, Gusella JF, Layman LC.

CHARGE syndrome and Kallmann syndrome (KS) are two distinct developmental disorders sharing overlapping features of impaired olfaction and hypogonadism. KS is a genetically heterogeneous disorder consisting of idiopathic hypogonadotropic hypogonadism (IHH) and anosmia, and is most commonly due to KAL1 or FGFR1 mutations. CHARGE syndrome, a multisystem autosomal-dominant disorder, is caused by CHD7 mutations. We hypothesized that CHD7 would be involved in the pathogenesis of IHH and KS (IHH/KS) without the CHARGE phenotype and that IHH/KS represents a milder allelic variant of CHARGE syndrome. Mutation screening of the 37 protein-coding exons of CHD7 was performed in 101 IHH/KS patients without a CHARGE phenotype. In an additional 96 IHH/KS patients, exons 6-10, encoding the conserved chromodomains, were sequenced. RT-PCR, SIFT, protein-structure analysis, and in situ hybridization were performed for additional supportive evidence. Seven heterozygous mutations, two splice and five missense, which were absent in > or = 180 controls, were identified in three sporadic KS and four sporadic normosmic IHH patients. Three mutations affect chromodomains critical for proper CHD7 function in chromatin remodeling and transcriptional regulation, whereas the other four affect conserved residues, suggesting that they are deleterious. CHD7's role is further corroborated by specific expression in IHH/KS-relevant tissues and appropriate developmental expression. Sporadic CHD7 mutations occur in 6% of IHH/KS patients. CHD7 represents the first identified chromatin-remodeling protein with a role in human puberty and the second gene to cause both normosmic IHH and KS in humans. Our findings indicate that both normosmic IHH and KS are mild allelic variants of CHARGE syndrome and are caused by CHD7 mutations. FAU - Kim, Hyung-Goo AU - Kim HG AD - Molecular Neurogenetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, and Department of Genetics, Harvard Medical School, Boston, MA 02114, USA. FAU - Kurth, Ingo AU - Kurth I FAU - Lan, Fei AU - Lan F FAU - Meliciani, Irene AU - Meliciani I FAU - Wenzel, Wolfgang AU - Wenzel W FAU - Eom, Soo Hyun AU - Eom SH FAU - Kang, Gil Bu AU - Kang GB FAU - Rosenberger, Georg AU - Rosenberger G FAU - Tekin, Mustafa AU - Tekin M FAU - Ozata, Metin AU - Ozata M FAU - Bick, David P AU - Bick DP FAU - Sherins, Richard J AU - Sherins RJ FAU - Walker, Steven L AU - Walker SL FAU - Shi, Yang AU - Shi Y FAU - Gusella, James F AU - Gusella JF